GlucoTrack, Inc. (GCTK)
0.66
+0.01
(+1.54%)
USD |
NASDAQ |
May 29, 16:00
0.65
-0.01
(-1.52%)
After-Hours: 20:00
GlucoTrack Cash from Investing (Quarterly) : 0.00 for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Abbott Laboratories | -20.32B |
| DexCom, Inc. | -298.50M |
| TransMedics Group, Inc. | -36.66M |
| AngioDynamics, Inc. | -1.507M |
| Alphatec Holdings, Inc. | -19.89M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.048M |
| Cash from Financing (Quarterly) | 0.591M |
| Free Cash Flow | -16.44M |
| Free Cash Flow Per Share (Quarterly) | -2.471 |
| Free Cash Flow to Equity (Quarterly) | -4.19M |
| Free Cash Flow to Firm (Quarterly) | -4.048M |
| Free Cash Flow Yield | -2.53K% |